Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Stepanova

Showing results (151-160 of 242) with videos related to

Pageof 25
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2018
Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertibZobair M Younossi, Maria Stepanova, Eric Lawitz, et al.
Obesity Surgery|June 10, 2010
A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosisZobair M Younossi, Sandra Page, Nila Rafiq, et al.
Obesity Surgery|May 27, 2008
A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH)Zobair M Younossi, Mohammed Jarrar, Clare Nugent, et al.
Journal of Hepatology|March 10, 2016
Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trialZobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Journal of Proteome Research|May 6, 2010
Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosisZobair M Younossi, Ancha Baranova, Maria Stepanova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2013
Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis CZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Hepatology Communications|December 21, 2023
The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver diseaseZobair M Younossi, Maria Stepanova, Reem Al Shabeeb, et al.
The Journal of Biological Chemistry|March 10, 2022
Prion protein with a mutant N-terminal octarepeat region undergoes cobalamin-dependent assembly into high-molecular weight complexesNathalie Daude, Agnes Lau, Ilaria Vanni, et al.
International Journal of Molecular Sciences|October 16, 2025
The Photodynamic Antibacterial Potential of New Tetracationic Zinc(II) Phthalocyanines Bearing 4-((Diethylmethylammonium)methyl)phenoxy SubstituentsGennady Meerovich, Dmitry Bunin, Ekaterina Akhlyustina, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 6, 2018
Effects of Treatment of Chronic Hepatitis B Virus Infection on Patient-Reported OutcomesZobair M Younossi, Maria Stepanova, Harry L A Janssen, et al.
Pageof 25

Showing results (151-160 of 242) with videos related to

Sort By:
Pageof 25
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2018
Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertibZobair M Younossi, Maria Stepanova, Eric Lawitz, et al.
Obesity Surgery|June 10, 2010
A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosisZobair M Younossi, Sandra Page, Nila Rafiq, et al.
Obesity Surgery|May 27, 2008
A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH)Zobair M Younossi, Mohammed Jarrar, Clare Nugent, et al.
Journal of Hepatology|March 10, 2016
Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trialZobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Journal of Proteome Research|May 6, 2010
Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosisZobair M Younossi, Ancha Baranova, Maria Stepanova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2013
Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis CZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Hepatology Communications|December 21, 2023
The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver diseaseZobair M Younossi, Maria Stepanova, Reem Al Shabeeb, et al.
The Journal of Biological Chemistry|March 10, 2022
Prion protein with a mutant N-terminal octarepeat region undergoes cobalamin-dependent assembly into high-molecular weight complexesNathalie Daude, Agnes Lau, Ilaria Vanni, et al.
International Journal of Molecular Sciences|October 16, 2025
The Photodynamic Antibacterial Potential of New Tetracationic Zinc(II) Phthalocyanines Bearing 4-((Diethylmethylammonium)methyl)phenoxy SubstituentsGennady Meerovich, Dmitry Bunin, Ekaterina Akhlyustina, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 6, 2018
Effects of Treatment of Chronic Hepatitis B Virus Infection on Patient-Reported OutcomesZobair M Younossi, Maria Stepanova, Harry L A Janssen, et al.
Pageof 25